SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-000778
Filing Date
2020-03-12
Accepted
2020-03-12 12:22:17
Documents
44
Period of Report
2020-01-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT odyssey_10q-013120.htm 10-Q 243786
2 CERTIFICATION odyssey_ex3101.htm EX-31.1 7612
3 CERTIFICATION odyssey_ex3102.htm EX-31.2 7514
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 odyssey_ex32.htm EX-32 3528
  Complete submission text file 0001683168-20-000778.txt   1322576

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE odyy-20200131.xml EX-101.INS 124540
6 XBRL SCHEMA FILE odyy-20200131.xsd EX-101.SCH 19621
7 XBRL CALCULATION FILE odyy-20200131_cal.xml EX-101.CAL 28634
8 XBRL DEFINITION FILE odyy-20200131_def.xml EX-101.DEF 55061
9 XBRL LABEL FILE odyy-20200131_lab.xml EX-101.LAB 131622
10 XBRL PRESENTATION FILE odyy-20200131_pre.xml EX-101.PRE 110922
Mailing Address 2372 MORSE AVE. IRVINE CA 92614
Business Address 2372 MORSE AVE. IRVINE CA 92614 702-751-1418
Odyssey Group International, Inc. (Filer) CIK: 0001626644 (see all company filings)

IRS No.: 471022125 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-200785 | Film No.: 20707793
SIC: 2833 Medicinal Chemicals & Botanical Products